Generon Pharma Private Limited
Founded in 2021 and headquartered in Maharashtra, India.
2021 | Nagpur, Maharashtra (India) | Active
Generon Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 9 Months
About Generon Pharma
Generon Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2021 (Three years and nine months 2 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Singh, Samir Lohi, and Arvind Sarathe serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MH2021PTC361087
- Company No.
361087
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Home Appliances
Pharmaceuticals
Who are the key members and board of directors at Generon Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Singh  | Director | 27-May-2021 | Current |
| Samir Lohi | Director | 27-May-2021 | Current |
| Arvind Sarathe | Director | 27-May-2021 | Current |
Financial Performance of Generon Pharma.
Enhance accessibility to Generon Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Generon Pharma?
Unlock access to Generon Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Xiti Agro (Opc) Private Limited
Samir Lohi is a mutual person
- Guruver Prakash Tata's Unrivalled Ayurveda Private Limited
Arvind Sarathe is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Generon Pharma?
Generon Pharma has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Generon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.